Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $54.2 Million - $63.4 Million
547,894 Added 29.13%
2,429,063 $281 Million
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $21.6 Million - $25.2 Million
-224,662 Reduced 10.67%
1,881,169 $193 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $40.4 Million - $42.7 Million
376,443 Added 21.77%
2,105,831 $230 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $108 Million - $197 Million
1,729,388 New
1,729,388 $197 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Tig Advisors, LLC Portfolio

Follow Tig Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tig Advisors, LLC with notifications on news.